Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.
Add photos to showcase Nuvalent’s culture
Add Nuvalent’s values
Share your experience of working at Nuvalent
Add jobs to your org chart to show candidates who they’ll work with
Publish company announcements to get more exposure